News Detail
Ahmedabad, 18 April 2024: The growth of the pharmaceutical industry in Gujarat has continued unabated in the financial year 2023-24, with the Gujarat State Food and Drug Control Administration (FDCA) issuing 133 approvals for allopathic drug manufacturing plants.
Source : The Times of India
Today news Ahmedabad
pharmaceutical exports
investment commitments
Gujarat pharmaceutical industry
Gujarat FDCA
allopathic drug manufacturing
Related News
- SC exempts Ramdev from personal appearance for next hearing in misleading ads case (30-04-2024)
- Tripura: Four Bihar youth held with banned cough syrup worth Rs 1.72 lakh (30-04-2024)
- Sugar content in Cerelac lower than FSSAI limit: Nestle (30-04-2024)
- US FDA approves First Drug Indicated in Patients with WHIM Syndrome (30-04-2024)
- Four-fold rise in immunodeficiency cases in seven years (30-04-2024)
- Drug firms told to set up system for 'prompt' recalls (30-04-2024)
- Amendments to tighten law on misleading drug ads stalled since 2020 (30-04-2024)
- Patanjali Group firms under DGGI scanner for non-payment of GST, fake ITC (30-04-2024)
- US FDA tightens scrutiny of lab-developed tests with new rule (30-04-2024)
- Uttarakhand suspends permissions of 14 products of Ramdev's pharma firms (30-04-2024)